Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured f...

FDA Recall #D-0384-2026 — Class II — March 3, 2026

Recall #D-0384-2026 Date: March 3, 2026 Classification: Class II Status: Ongoing

Product Description

Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Recalling Firm

Rising Pharma Holding, Inc. — East Brunswick, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1200 bottles

Distribution

Nationwide within the U.S

Code Information

Lot #: 1TM0524003A, Exp. Date 09/2026.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated